Meanwhile, the S&P BSE Sensex was down 86.91 points or 0.45% at 19,354.16.
On BSE, 2,172 shares were traded in the counter as against average daily volume of 16,426 shares in the past one quarter.
The stock hit a high of Rs 764.60 and a low of Rs 758.10 so far during the day. The stock had hit a 52-week high of Rs 964 on 12 September 2012. The stock had hit a 52-week low of Rs 711 on 18 June 2012.
The stock had outperformed the market over the past one month till 10 June 2013, falling 3.1% compared with the Sensex's 3.19% slide. The scrip had also outperformed the market in past one quarter, rising 2.95% as against Sensex's 1.23% slide.
The large-cap pharmaceutical company has equity capital of Rs 102.37 crore. Face value per share is Rs 5.
Before turning ex-dividend, the stock offered a dividend yield of 0.98% based on the closing price of Rs 764.30 on Monday, 10 June 2013.
Cadila Healthcare's consolidated net profit surged 53.6% to Rs 262.46 crore on 16.5% growth in net sales to Rs 1565.76 crore in Q4 March 2013 over Q4 March 2012.
Cadila Healthcare is a global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare products.
Powered by Capital Market - Live News
